Drotrecogin alfa (activated) in the subgroup of patients with multiple organ dysfunction (MOD) during a global, single-arm, open-label trial in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS

Detalles Bibliográficos
Autores principales: Vincent, J, Bernard, G, Dhainaut, J, Janes, J, Wright, T, Gaillez, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099702/
http://dx.doi.org/10.1186/cc2582
_version_ 1782326527058247680
author Vincent, J
Bernard, G
Dhainaut, J
Janes, J
Wright, T
Gaillez, C
author_facet Vincent, J
Bernard, G
Dhainaut, J
Janes, J
Wright, T
Gaillez, C
author_sort Vincent, J
collection PubMed
description
format Online
Article
Text
id pubmed-4099702
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40997022014-09-23 Drotrecogin alfa (activated) in the subgroup of patients with multiple organ dysfunction (MOD) during a global, single-arm, open-label trial in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS Vincent, J Bernard, G Dhainaut, J Janes, J Wright, T Gaillez, C Crit Care Poster Presentation BioMed Central 2004 2004-03-15 /pmc/articles/PMC4099702/ http://dx.doi.org/10.1186/cc2582 Text en
spellingShingle Poster Presentation
Vincent, J
Bernard, G
Dhainaut, J
Janes, J
Wright, T
Gaillez, C
Drotrecogin alfa (activated) in the subgroup of patients with multiple organ dysfunction (MOD) during a global, single-arm, open-label trial in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS
title Drotrecogin alfa (activated) in the subgroup of patients with multiple organ dysfunction (MOD) during a global, single-arm, open-label trial in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS
title_full Drotrecogin alfa (activated) in the subgroup of patients with multiple organ dysfunction (MOD) during a global, single-arm, open-label trial in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS
title_fullStr Drotrecogin alfa (activated) in the subgroup of patients with multiple organ dysfunction (MOD) during a global, single-arm, open-label trial in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS
title_full_unstemmed Drotrecogin alfa (activated) in the subgroup of patients with multiple organ dysfunction (MOD) during a global, single-arm, open-label trial in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS
title_short Drotrecogin alfa (activated) in the subgroup of patients with multiple organ dysfunction (MOD) during a global, single-arm, open-label trial in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS
title_sort drotrecogin alfa (activated) in the subgroup of patients with multiple organ dysfunction (mod) during a global, single-arm, open-label trial in adult patients with severe sepsis (enhance): comparisons with prowess
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099702/
http://dx.doi.org/10.1186/cc2582
work_keys_str_mv AT vincentj drotrecoginalfaactivatedinthesubgroupofpatientswithmultipleorgandysfunctionmodduringaglobalsinglearmopenlabeltrialinadultpatientswithseveresepsisenhancecomparisonswithprowess
AT bernardg drotrecoginalfaactivatedinthesubgroupofpatientswithmultipleorgandysfunctionmodduringaglobalsinglearmopenlabeltrialinadultpatientswithseveresepsisenhancecomparisonswithprowess
AT dhainautj drotrecoginalfaactivatedinthesubgroupofpatientswithmultipleorgandysfunctionmodduringaglobalsinglearmopenlabeltrialinadultpatientswithseveresepsisenhancecomparisonswithprowess
AT janesj drotrecoginalfaactivatedinthesubgroupofpatientswithmultipleorgandysfunctionmodduringaglobalsinglearmopenlabeltrialinadultpatientswithseveresepsisenhancecomparisonswithprowess
AT wrightt drotrecoginalfaactivatedinthesubgroupofpatientswithmultipleorgandysfunctionmodduringaglobalsinglearmopenlabeltrialinadultpatientswithseveresepsisenhancecomparisonswithprowess
AT gaillezc drotrecoginalfaactivatedinthesubgroupofpatientswithmultipleorgandysfunctionmodduringaglobalsinglearmopenlabeltrialinadultpatientswithseveresepsisenhancecomparisonswithprowess

Ejemplares similares